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Abstract
Background: Copy number variation (CNV) in the human genome is recognised as a widespread
and important source of human genetic variation. Now the challenge is to screen for these CNVs
at high resolution in a reliable, accurate and cost-effective way.
Results:  Multiplex Amplifiable Probe Hybridisation (MAPH) is a sensitive, high-resolution
technology appropriate for screening for CNVs in a defined region, for a targeted population. We
have developed MAPH to a highly multiplexed format ("QuadMAPH") that allows the user a four-
fold increase in the number of loci tested simultaneously. We have used this method to analyse a
genomic region of 210 kb, including the MSH2 gene and 120 kb of flanking DNA. We show that
the QuadMAPH probes report copy number with equivalent accuracy to simplex MAPH, reliably
demonstrating diploid copy number in control samples and accurately detecting deletions in
Hereditary Non-Polyposis Colorectal Cancer (HNPCC) samples.
Conclusion: QuadMAPH is an accurate, high-resolution method that allows targeted screening of
large numbers of subjects without the expense of genome-wide approaches. Whilst we have
applied this technique to a region of the human genome, it is equally applicable to the genomes of
other organisms.
Background
Recent work has described the abundance of copy number
variants (CNVs) in the human genome [1-4]. Not only
have these studies demonstrated the presence of CNVs in
apparently healthy individuals, and hence their consider-
able contribution to overall genetic variation, they have
also shown CNVs to be an important contributor to sus-
ceptibility to complex disease [5-10].
A variety of different methods are available for the detec-
tion of genomic copy number changes [reviewed in
[11,12]] each with their own advantages and disadvan-
tages with respect to resolution, accuracy, applicability to
large-scale studies and cost. Methods for copy number
measurement can generally be divided into two broad cat-
egories: those that are suitable for global detection of
novel variants (for example, array CGH and paired-end
sequencing) as illustrated by [1,3,13,14], and more tar-
geted methods that measure copy number at a particular
locus, or relatively small number of loci, in a targeted pop-
ulation of probands (for example real time quantitative
PCR, MAPH, MLPA and PRT) [15-18].
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Multiplex Amplifiable Probe Hybridisation (MAPH) is a
versatile and simple semi-quantitative method for direct
determination of DNA copy number [16,19]. The method
relies on the fact that amplifiable probes can be hybrid-
ised to genomic DNA fixed onto a nylon membrane, strin-
gently washed, and then amplified so that the amount of
amplified product is directly proportional to the copy
number in the genomic DNA. Each amplifiable probe is a
different length so that the probes can be resolved by elec-
trophoresis. MAPH probes are also insensitive to substitu-
tional polymorphisms making them highly suitable for
copy number measurement. In addition, MAPH's multi-
plicity and flexible resolution means it is a method highly
suited to accurate high resolution copy number screening.
To date, copy number measurement by MAPH has utilised
a single set of probes, consisting of specifically designed
amplicons cloned into a single vector, that measure the
relative copy number of up to 40 targets simultaneously
[20,21]. In order to screen for potential copy number
changes at a greater number of loci simultaneously, we
have introduced a novel scheme for probe generation, and
developed the MAPH technology to use probe sets in a
four-fold multiplex, here termed "QuadMAPH". This for-
mat has been particularly designed to allow thorough
copy-number screening of 100-200 kb regions (for exam-
ple, encompassing the genomic extent of a medium-sized
human gene), at high (1-2 kb) resolution in large num-
bers of genomic DNA samples from selected cohorts. In
this report we describe the development of a QuadMAPH
screening method applied to a genomic region of over 200
kb around the MSH2 gene.
Results
To generate a large number of MAPH probes within a
specified region, restriction enzyme digestion of isolated
BAC DNA was carried out to produce hundreds of frag-
ments spanning a range of sizes. The individual combina-
tion of enzymes was selected of the basis of computer
generated restriction enzyme prediction from the BAC
sequence (macro (Microsoft Word) available on request).
The digest simulation was used not only to predict the
proportion of fragments that would be usable as MAPH
probes but also the location of the usable probes with
respect to BAC sequence to ensure a comprehensive cov-
erage of the region of interest. The AluI, HaeIII, RsaI digest
simulation of BAC RP11-1084A21 predicted that from a
total of 2243 (digest) fragments, 221 would be usable. Of
the unusable fragments, 1336 were considered to be too
short (<80 bp) and 13 too long (>500 bp). Among the
894 fragments in the 80-500 bp range, 149 were too AT
rich (GC<35%) and 584 contained more than 20 bp of
match to a masked repeat.
Following cloning, 864 colonies were picked from across
the four vector systems and subjected to sequencing and
bioinformatic analysis. 455 fragments satisfied the criteria
for being usable MAPH probes, i.e., single copy, 80 to
≈500 base pairs in length and a GC content of 35% or
above. The fragments ranged in actual size from 86 to 520
bp, and 37 to 62% GC. Following removal of duplicates
in which the same fragment had been cloned more than
once (in the same vector or between several vectors), 168
unique probes were accepted. Probe sets were assembled,
taking into consideration coverage of the MSH2 region,
GC content and range of probe sizes resolvable by capil-
lary electrophoresis. Three control probes cloned into
pZero2 were also included in the set. These consisted of X
and Y linked probes and a non-human probe. Of the 168
unique MAPH probes for MSH2  generated by this
method, 107 probes were assembled into an initial Quad-
MAPH set to screen the MSH2 locus at an average resolu-
tion of one probe per 1.96 kb. Distribution of MSH2
probes and coverage of the region from the initial Quad-
MAPH set is illustrated in Figure 1.
To assess the ability of QuadMAPH to identify deletion or
duplication events, and to evaluate the measurement
accuracy of the assay, a direct comparison was made
between the HNPCC probe set [21] and our QuadMAPH
set. MAPH using both probe sets was performed for 96
control DNA samples and 6 DNA samples with known
MSH2 exonic deletions, which had been independently
characterised by the referring laboratory. Example Quad-
MAPH traces for an individual heterozygous for exonic
deletions of the MSH2 gene and a control are illustrated
in Figure 2.
Analysis was carried out as previously described [20].
Briefly, experimental values are normalised relative to
other probe results to give a normalised ratio (NR). The
normalised ratios can be used as an index of the relative
intensity of a given peak in a given sample, and hence be
used to detect copy number changes. In the absence of
copy number changes, a mean of 1 is expected, equivalent
to a dosage of two copies per cell. A heterozygous deletion
and a heterozygous duplication are expected to result in
values of 0.5 and 1.5 respectively. Normalised ratios from
control samples approximated well to a normal distribu-
tion. The accuracy of measurement by each probe was
evaluated by calculating the standard deviation (SD) of
the normalised ratio. The mean and SD of the NR values
obtained for probes demonstrating diploid dosage and
heterozygous deletion are shown in Table 1. Although
individual probes differed in measurement accuracy, the
average standard deviation of measurements, as illus-
trated in Table 1, was 0.0613 for HNPCC MAPH and
0.0671 for QuadMAPH. Assuming a normal (Gaussian)
error distribution, this predicts a per test false positive rateBMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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of 9.9 × 10-7 for HNPCC MAPH and 7.8 × 10-6 for Quad-
MAPH at a threshold of 1 +/- 0.3. For deletion events, we
predict a per test false negative rate of 1.5 × 10-4 and 7.2 ×
10-4 for HNPCC and QuadMAPH respectively. For dupli-
cation events, we predict a per test false negative rate of 5.5
× 10-4 and 1.4 × 10-3 for HNPCC and QuadMAPH respec-
tively.
Discussion
The use of MAPH in assessing copy number changes at
new loci requires the generation of new probe sets, which
can be a lengthy and time-consuming process if individ-
ual amplicons need to be designed and cloned. Since
many of the most likely candidates for disease association
are in regions of the genome that also contain repeat ele-
ments, the positioning of single-copy probes can be prob-
lematic. Therefore efficient screening of regions for copy
number variants by MAPH has necessitated the develop-
ment of QuadMAPH and with it, the introduction of new
cloning systems and a new method of generating probes.
Previously, MAPH probes have been made by designing
and cloning individual PCR amplicons [20-22], which is
not always appropriate for covering large genomic
regions, or if numerous probes are required. In order to
screen regions of approximately 200 kb in size with a
probe approximately every 1-2 kb, we have established an
alternative approach for MAPH probe generation, by
which sets of probes are prepared by shotgun cloning of
random short fragments from a BAC clone covering the
region of interest. This method of producing MAPH
probes is both efficient and cost-effective with respect to
the number of probes generated and can be easily and rap-
idly applied to new loci which are not covered by com-
mercially available technologies. An important step in the
random generation of fragments is the choice of restric-
tion enzymes in the initial BAC DNA digest, which dic-
tates the number of usable MAPH probes produced. The
use of double stranded linkers allows simultaneous PCR
amplification of all fragments generated by this digestion.
Digested BAC DNA was subject to two rounds of size-
selection, which resulted in a reasonable distribution of
fragments in the size range suitable for MAPH probes and
was also necessary to offset any potential bias towards
small fragments in the subsequent cloning and transfor-
mation steps.
Since the clones were generated randomly, unsurprisingly
there was a degree of redundancy of fragments between
vectors, but this allowed flexibility in the choice of probes
for each set, and also produced a reserve of probes that
could be used to improve on resolution or to confirm any
potential copy number changes. In fact, once a set of
clones has been generated, these can be stored in their 96-
well microtitre plates at -20°C to -80°C thus providing a
collection from which to make additional MAPH probe
sets with minimal additional labour. Despite the high
density of repetitive elements (SINEs) at the MSH2 locus,
Distribution of probes produced using a random cloning approach for MSH2 QuadMAPH set 1 Figure 1
Distribution of probes produced using a random cloning approach for MSH2 QuadMAPH set 1. The window 
shows 210 kb DNA corresponding to BAC RP11-1084A21 and the location of the MSH2 gene on the UCSC genome browser 
[27,28] (March 2006 assembly). The positions of the probes are represented by the vertical black lines within the green box.BMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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this approach generated good probe coverage across the
region, as illustrated in Figure 1. If probe density is not
sufficient to interrogate a specific region, then gaps can be
filled by custom design of a small number of supplemen-
tary probes. Custom probes can be cloned into any one of
four vectors to fit into size gaps in the profile for the vector
chosen.
All four vectors can be multiplexed in any combination or
used in MAPH on their own. Therefore, using four cloning
systems allows the generation of four independent MAPH
probe sets and subsequently a substantial increase in the
number of targets that can be interrogated in a single test.
The number of loci that can be analysed at once is deter-
mined by the number of probes in the probe set. Theoret-
ically, the number of probes per set is only limited by the
resolution and the number of fluorophores detectable
after capillary electrophoresis, and in the case of generat-
ing probes by a random shotgun cloning approach, the
size range of probes produced in the initial digest. Whilst
A combined four-colour QuadMAPH trace for (A) an individual heterozygous for exonic deletions of the MSH2 gene and (B) a  control Figure 2
A combined four-colour QuadMAPH trace for (A) an individual heterozygous for exonic deletions of the MSH2 
gene and (B) a control. Profiles from the pZero2, pGemT, pBS and XpUC probe sets are illustrated as blue (FAM), red 
(ROX), black (NED) and green (HEX) peaks respectively. The dashed box indicates the zoomed-in area illustrated in panels 
(C) and (D). Probes indicating a heterozygous deletion are shown by the arrows.BMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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our initial MSH2 QuadMAPH set consisted of 110 probes,
additional probes can be included. In this work, by choos-
ing an initial copy number screening resolution of a probe
every 1-2 kb, the boundaries of any copy number variants
discovered could then be defined within the range of long
PCR, and junction-fragment analysis can be used to estab-
lish a rapid, specific PCR assay for the variant.
MAPH has previously been demonstrated as an accurate
and precise assay for measurement of copy number [20-
22]. After extensive experimental work dissecting and ana-
lysing factors affecting MAPH's accuracy and robustness,
improvements have been made in the working method.
PCR cycling modifications, and adherence to a strict wash
protocol and wash solutions appropriate to the %GC con-
tent of the probe set, have reduced copy number measure-
ment error and improved the reliability and
reproducibility of the assay. As a consequence of this, the
standard deviations reported here are considerably
smaller than those reported by Hollox et al [20]. Associ-
ated with this is a substantial reduction in the predicted
incidence of false positive and false negative results. The
incorporation of control probes within a probe set, such
as X and Y linked probes and a non-human probe, allow
the user to assess non-specific probe binding and adjust
washing conditions as necessary, as well as confirm that
any copy number changes can be detected accurately
based on the responsiveness of the control probes.
By comparison of data obtained by simplex MAPH with
those by QuadMAPH, we have also demonstrated that
multiplexing four probe sets is achieved with no ensuing
loss of measurement accuracy, as indicated by the false
positive and false negative predictions. Although MLPA
has been successfully used in a two-colour format [23,24]
these studies examined totals of 28 and 45 probes respec-
tively, and we are not aware of successful use of MLPA at
probe multiplicities approaching those in this report.
Since MLPA also depends on pairwise ligation of half-
probes, there may be a very large number of opportunities
for MLPA using a large number of probes and multiple
primers to create artefactual products; by contrast, MAPH
probes in different vectors are not expected to interact
with one another, and we have shown here that 110
probes perform well together. In summary, we believe
QuadMAPH has the capacity to screen large numbers of
loci simultaneously on a large number of samples.
Conclusion
Genome wide studies have revealed the extent of copy
number variation, but detailed investigation of specific
regions creates a different challenge. At the present time,
obtaining copy number variation information at the
nucleotide level, on a genome-wide scale, in hundreds or
thousands of individuals is not a realistic prospect for
many investigators. For those who wish to examine copy
number variation of a defined region(s) (of, for example,
100-200 kb) our four vector systems, combined with
QuadMAPH, constitute an accurate, high-resolution
method that allows targeted screening of large numbers of
subjects without the expense of genome-wide approaches.
Methods
Preparation of BAC DNA linkered library
BAC DNA from RP11-1084A21, a clone obtained from
BACPAC resources [25] covering the MSH2  gene and
flanking regions, was prepared by alkaline lysis purifica-
tion and 250 ng digested to completion with enzymes
AluI,  HaeIII,  RsaI. A fill-in step with 2.5 U Klenow
polymerase and 1 μl 2.5 mM dNTPs was carried out at
room temperature (20-25°C) for 1 hour, before purifica-
tion by phenol/chloroform extraction and ethanol precip-
itation and ligation of fragments with double-stranded
linkers. Linkers AH1 and AH2, incorporating restriction
enzyme sites for AluI and HaeIII, were prepared at a final
concentration of 500 μM dsDNA linker and 0.1 M NaCl
by mixing equal volumes of 1 mM of each oligo AH1F
(ACTGTCCAGCTTCGATGGCC) with AH1R (GGCCATC-
GAAGCTGGACA) (to generate linker AH1) and AH2F
(CTAATCGGCCTGTGAGAGCT) with AH2R (AGCTCT-
CACAGGCCGATT) (for linker AH2) in the presence of 0.1
M NaCl and incubating at 65°C for 20 min followed by
Table 1: Mean normalised ratio (NR) and standard deviation (SD) of probes showing diploid dosage and those known to be involved in 
a heterozygous deletion.
Control probes Probes within deletion
NR SD NR SD
Probe set: HNPCC 1.0005*
(n = 3360)
0.0613 0.4952
(n = 61)
0.0552
Probe set: QuadMAPH 1.0003*
(n = 9995)
0.0671 0.5986
(n = 58)
0.0628
*Initial normalisation of all the data included samples which were subsequently scored as deleted for a particular probe, leading to these control 
samples having an average value that is very slightly greater than 1.BMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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slow cooling. 25 ng BAC DNA digest fragments were then
ligated at room temperature overnight with 100 μM AH1
and AH2 and 1 U T4 DNA ligase in a buffer containing 50
mM Tris-HCl, 10 mM MgCl2, 10 mM Dithiothreitol and 1
mM ATP. Linkered fragments were purified using the
QIAquick PCR purification kit (Qiagen) according to the
manufacturer's instructions, eluting in 50 μl EB buffer.
In order to generate a sufficient quantity of fragments for
subsequent size-selection, 2.5 μl of linkered BAC digest
fragments were used to seed 8 separate 50 μl PCR reac-
tions. Products were amplified using primers AH1F and
AH2F under conditions of 70°C for 1 min, followed by 30
cycles of 95°C for 1 min, 60°C for 1 min, 70°C for 1 min.
The PCR products were then pooled and purified using
the QIAquick PCR purification kit (Qiagen), eluting in 30
μl EB. The sequences of the linkers and primers used to
amplify the fragments are shown in Figure 3A.
Size-selection of linkered fragments and preparation for 
cloning
Fragments were saturated with ethidium bromide before
electrophoresis and separated on 1.5% agarose gel at
100V for precisely 90 min. A gel slice containing frag-
ments in the size range 100 to 600 base pairs was excised
using a Dark Reader Transilluminator. The gel slice was
placed into a fresh agarose gel in an inverted orientation
and the electrophoresis repeated at 100V for precisely 90
min to collect all fragments from the gel slice back into a
single band. DNA was extracted from the gel using a
QIAquick gel extraction kit (Qiagen) eluting in 30 μl EB
buffer. Linker sequences were removed by restriction
enzyme digestion with AluI and HaeIII and dephosphor-
ylation carried out by addition of 1 U Calf Intestinal Alka-
line Phosphatase for the final hour of digestion. A
proportion of fragments were 3' dA tailed by incubating at
72°C for 1 hour with 1× BufferIV (ABgene), 1.6 mM
MgCl2, 0.2 mM dATP and 1U Taq Polymerase to enable
ligation into T-vector systems. All fragments were then
size selected for a second time, as above.
Vector preparation
In addition to the established plasmid vectors used for
cloning MAPH probes, QuadMAPH required the intro-
duction of two further vectors, pBS and XpUC. The T-vec-
tor pBS was prepared by restriction enzyme digestion of
pBluescript II SK+ plasmid DNA (Stratagene) with EcoRV,
followed by incubation with dideoxythymidine triphos-
Sequences of the double-stranded linkers (A) ligated to the digested fragments and the primers used for universal amplification,  and (B) inserted into the pUC19 vector to create the XpUC vector Figure 3
Sequences of the double-stranded linkers (A) ligated to the digested fragments and the primers used for uni-
versal amplification, and (B) inserted into the pUC19 vector to create the XpUC vector. The central EcoRV site is 
shown in red and the flanking recognition sequences for the two XcmI sites highlighted bold. The base used to form the 3' T 
overhang is shown in blue.
AH1 linker AH2 linker
Amplification primer Amplification primer
AH1 linker AH2 linker
Amplification primer Amplification primer
A
BBMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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phate (ddTTP) and terminal transferase [26] to create a
single 3' T overhang.
An additional customised T-vector, XpUC, was prepared
from a modified pUC19 plasmid by digestion with XcmI.
A linker was designed that contained an EcoRV site flanked
by two XcmI restriction enzyme sites. Each XcmI site was
specifically designed to have a thymine in the fifth 5' to 3'
unspecified base position, such that a 3' T overhang would
be created following digestion. The sequence of the dou-
ble stranded linker is shown in Figure 3B. The linker frag-
ment was inserted into the pUC19 plasmid between the
EcoRI and BamHI sites of the polylinker. To aid purifica-
tion of the final vector, a 1 kb 'stuffer' fragment from
ΦX174 DNA-HaeIII digest was ligated into the EcoRV site
at the centre of the linker. XpUC vector was prepared from
this modified plasmid by digestion with SacII (to linearise
the plasmid via a site in the 'stuffer' fragment) and subse-
quently XcmI. To limit the potential for recircularisation
or dimer formation during ligation, a self-ligation step fol-
lowed by selection of the unligated linear vector from an
agarose gel was carried out.
Cloning and transformation
Approximately 50-100 ng of size-selected DNA fragments,
in a volume of 2 μl, were ligated with 25 ng of one of four
different plasmid vectors, pZero2 [Invitrogen, see [16]],
pGemT (Promega), pBS and XpUC, and purified by etha-
nol precipitation prior to transformation. Transformation
using 2 μl ligation reaction per 25 μl E. coli Top 10 cells
(Invitrogen) was carried out by electroporation at 12.5
kV/cm (200Ω, 25 μF). Cells were incubated in 500 μl SOC
for one hour at 37°C, shaking to mix. 25 μl 1 M IPTG was
added for cloning into pGemT and pBS. Cells were spread
on LB agar plates containing either 50 μg/ml Kanamycin
for pZero2 or 100 μg/ml Ampicillin for pGemT, pBS and
XpUC and incubated at 37°C overnight. For pGemT and
pBS 25 μl of XGal (25 mg/ml) was added to each plate
before spreading to allow blue/white screening. Following
overnight incubation at 37°C, colonies were picked into
individual wells of 96-well microtitre plates containing
100 μl LB broth, 4% glycerol and the appropriate antibi-
otic and incubated at 37°C overnight.
Identification of usable MAPH probes
Inserts from recombinant plasmids were amplified by
PCR directly from the 96-well microtitre plate cultures
using primer 1277 (TGGCGAAAGGGGGATGTGCTG)
common to all vectors and a vector specific primer (PZA
for pZero2, PGB for pGemT, PBSA for pBS or PUCB for
XpUC clones; Table 2), with 25 cycles of 95°C for 30 s,
60°C for 1 min and 70°C for 1 min. PCR products were
purified using AMPure (Agencourt) and 20-30 ng
sequenced with primer 1277 using 0.25 μl BigDye Termi-
nator v3.1 mix and 3.75 μl 5× BigDye sequencing buffer
(Applied Biosystems) using standard cycle sequencing
conditions. Sequenced products were purified using
CleanSEQ (Agencourt) following the manufacturer's pro-
tocol.
The sequences of all cloned fragments were subject to bio-
informatic analysis to identify those fragments that satis-
fied criteria for being usable MAPH probes. All insert
sequences were aligned with the human genome using the
BLAT search facility at UCSC (March 2006 assembly
[27,28]). Any inserts which failed to match the source
BAC or contained a perfect match of over 30 bases to
another genomic location were rejected. Size and GC con-
tent were also taken into consideration. Finally, the
remaining probes were aligned with the BAC sequence
using align 2 sequences blast facility at NCBI [29]. This
allowed the precise location of each insert within the
region to be recorded. We will be happy to make the cus-
tom bioinformatic tools used freely available to interested
researchers.
Plasmid DNA from selected clones was isolated using the
R.E.A.L. Prep 96 plasmid procedure (Qiagen) according to
the manufacturer's instructions, with the exception that
all inversion steps were replaced by gentle mixing by
pipette to reduce potential well-to-well contamination of
plasmid DNA. MAPH probes were amplified from puri-
fied plasmid DNA using vector specific primers: PZA with
PZB for pZero2; PGA with PGB for pGemT; PBSA2 with
PBSB for pBS, and PUCA with PUCB for XpUC. The
sequences of all primers are shown in Table 2. Amplifica-
tion was carried out for 20 cycles of 95°C for 1 min, 60°C
for 1 min and 70°C for 1 min. Product concentration was
Table 2: Sequences of all MAPH primers used in this study.
Primer name Sequence
Fam PZA Fam-AGTAACGGCCGCCAGTGTGCTG
PZB CGAGCGGCCGCCAGTGTGATG
Rox PGA Rox-CCGCCATGGCCGCGGGAT
PGB AGGCGGCCGCACTAGTGAT
Ned-PBSB Ned-GGTCGACGGTATCGATAAGCTTG
PBSA CCCCCGGGCTGCAGGAATTC
PBSA2 GCCCCCGGGCTGCAGGAATTC
Hex-PUCB Hex-CGACTCTAGAGGATCCAGAGG
PUCA CGACGGCCAGTGAATTCCAGBMC Genomics 2009, 10:453 http://www.biomedcentral.com/1471-2164/10/453
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estimated on an agarose gel and probes mixed in vector
specific sets to give a final concentration of 2 ng/μl per
probe following purification by QIAquick PCR purifica-
tion kit (Qiagen).
MAPH
UK control samples used in this study consisted of ECACC
Human Random control (HRC) panels 1 and 2 [30].
HNPCC disease cohort DNA was kindly supplied by
Wessex Regional Genetics Laboratory. MAPH was carried
out according to [16,20] with the following modifica-
tions. During the hybridisation step, E. coli/HaeIII DNA
(at 3.5 mg/ml) was omitted. For QuadMAPH, hybridisa-
tion of the four independent probe sets occurred simulta-
neously in the same hybridisation tube, with additional
20 pmol of each of the 'end-blocking' primers PGA, PGB,
PBSA, PBSB, PUCA and PUCB. Washing to remove
unbound probes was carried out at 65°C using wash solu-
tions of 1 × SSC, 1%SDS for solution 1 and 0.1 × SSC,
0.1%SDS for solution 2. Washed filters were transferred to
50 μl 1× buffer IV (ABgene) and heated at 95°C for 5 min.
1 μl of this was used to seed subsequent PCR reactions.
For MAPH utilising a single probe set, PCR was carried out
using Fam-PZA with PZB for 25 cycles of 95°C for 30 s,
60°C for 1 min, 70°C for 1 min, followed by a final exten-
sion at 70°C for 40 min. 1 μl of PCR product was mixed
with 10 μl HiDi formamide and ROX500 marker (Applied
Biosystems). PCR to amplify the recovered probes in
QuadMAPH was achieved in two duplex PCR reactions
using primers FAM-PZA and PZB in a reaction with ROX-
PGA and PGB, and NED-PBSB and PBSA2 with HEX-
PUCB and PUCA, using PCR conditions detailed above. 1
μl of each duplex PCR product was mixed with 10 μl HiDi
formamide (Applied Biosystems). All samples were dena-
tured at 96°C for 3 min and then placed on ice prior to
electrophoresis on an ABI 3100 36 cm capillary, using
POP-4 polymer with an injection time of 45 s. Peaks were
quantified using Genescan and Genotyper software
(Applied Biosystems) using a MAPH trace as an internal
size standard in place of ROX500 for the QuadMAPH
data. Data analysis using Excel (Microsoft) was carried out
as previously described [20]. For QuadMAPH, each inde-
pendent probe set was analysed separately. Full details of
macros, probes and probe sets used are available on
request.
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